Angiodynamics Inc (ANGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 05-2018 | 02-2018 | 11-2017 | 08-2017 | 05-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,096 | 52,292 | 49,856 | 48,200 | 47,544 |
| Marketable Securities | 1,317 | 1,281 | 1,260 | 1,215 | 1,215 |
| Receivables | 39,401 | 41,827 | 42,073 | 41,283 | 44,523 |
| Inventories | 39,274 | 56,564 | 54,032 | 55,425 | 54,506 |
| Other current assets | 9,642 | 0 | 0 | 0 | 0 |
| TOTAL | $168,032 | $156,569 | $152,495 | $150,722 | $153,914 |
| Non-Current Assets | |||||
| PPE Net | 25,715 | 43,058 | 43,767 | 44,353 | 45,234 |
| Intangibles | 398,491 | 495,764 | 498,689 | 502,835 | 506,927 |
| Other Non-Current Assets | 113,234 | 3,038 | 2,855 | 2,431 | 1,886 |
| TOTAL | $537,440 | $541,860 | $545,311 | $549,619 | $554,047 |
| Total Assets | $705,472 | $698,429 | $697,806 | $700,341 | $707,961 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 |
| Accounts payable and accrued liabilities | 15,775 | 16,350 | 21,800 | 17,421 | 18,087 |
| Accrued Expenses | 34,426 | 30,973 | 30,800 | 32,264 | 38,804 |
| Other current liabilities | 2,100 | 2,080 | 2,060 | 9,638 | 9,625 |
| TOTAL | $57,301 | $54,403 | $59,660 | $64,323 | $71,516 |
| Non-Current Liabilities | |||||
| Long Term Debt | 86,621 | 87,798 | 88,973 | 90,147 | 91,320 |
| Other Non-Current Liabilities | 1,782 | 1,938 | 1,947 | 1,957 | 3,986 |
| TOTAL | $105,576 | $105,698 | $116,926 | $118,134 | $121,418 |
| Total Liabilities | $162,877 | $160,101 | $176,586 | $182,457 | $192,934 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,886 | 36,805 | 36,745 | 36,716 | 36,581 |
| Common Shares | 370 | 370 | 369 | 368 | 367 |
| Retained earnings | 5,129 | 3,027 | -10,992 | -11,240 | -11,007 |
| Other shareholders' equity | -666 | -351 | -560 | -755 | -1,038 |
| TOTAL | $542,595 | $538,328 | $521,220 | $517,884 | $515,027 |
| Total Liabilities And Equity | $705,472 | $698,429 | $697,806 | $700,341 | $707,961 |